Beta-carotene takes a collective beating

Various studies of Beta-carotene have been halted early due to increased morbidity and mortality with Beta-carotene supplementation. These studies provide strong evidence that Beta-carotene has no benefit against heart disease or cancer, as well as possible evidence that it can cause harm in high-ri...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 1996-01, Vol.347 (8996), p.249
1. Verfasser:	Rowe, P M
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antioxidants - administration & dosage Antioxidants - adverse effects beta Carotene Cancer Cardiovascular disease Cardiovascular diseases Carotenoids - administration & dosage Carotenoids - adverse effects Clinical trials Clinical Trials as Topic Dietary supplements Female Humans Lung Neoplasms - prevention & control Male Morbidity Mortality Vitamin A Vitamin A - administration & dosage Vitamin A - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Various studies of Beta-carotene have been halted early due to increased morbidity and mortality with Beta-carotene supplementation. These studies provide strong evidence that Beta-carotene has no benefit against heart disease or cancer, as well as possible evidence that it can cause harm in high-risk individuals.
ISSN:	0140-6736 1474-547X
DOI:	10.1016/s0140-6736(96)90413-4